These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22328377)

  • 1. Galactose-Inducible promoters in Cryptococcus neoformans var. grubii.
    Baker LG; Lodge JK
    Methods Mol Biol; 2012; 845():211-26. PubMed ID: 22328377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three galactose inducible promoters for use in C. neoformans var. grubii.
    Ruff JA; Lodge JK; Baker LG
    Fungal Genet Biol; 2009 Jan; 46(1):9-16. PubMed ID: 18952189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cryptococcus neoformans GAL7 gene and its use as an inducible promoter.
    Wickes BL; Edman JC
    Mol Microbiol; 1995 Jun; 16(6):1099-109. PubMed ID: 8577246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A unique chromosomal rearrangement in the Cryptococcus neoformans var. grubii type strain enhances key phenotypes associated with virulence.
    Morrow CA; Lee IR; Chow EW; Ormerod KL; Goldinger A; Byrnes EJ; Nielsen K; Heitman J; Schirra HJ; Fraser JA
    mBio; 2012; 3(2):. PubMed ID: 22375073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyurea enhances post-fusion hyphal extension during sexual development in C. neoformans var. grubii.
    Zulkifli MN; Kaur JN; Panepinto JC
    Mycopathologia; 2012 Mar; 173(2-3):113-9. PubMed ID: 21952836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UGE1 and UGE2 regulate the UDP-glucose/UDP-galactose equilibrium in Cryptococcus neoformans.
    Moyrand F; Lafontaine I; Fontaine T; Janbon G
    Eukaryot Cell; 2008 Dec; 7(12):2069-77. PubMed ID: 18820075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of conditional mutations in genes essential for viability of Cryptococcus neoformans.
    Ianiri G; Boyce KJ; Idnurm A
    Curr Genet; 2017 Jun; 63(3):519-530. PubMed ID: 27783209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of whole-genome responses of the human AIDS-associated yeast pathogen Cryptococcus neoformans var grubii: nitric oxide stress and body temperature.
    Chow ED; Liu OW; O'Brien S; Madhani HD
    Curr Genet; 2007 Sep; 52(3-4):137-48. PubMed ID: 17661046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India.
    Chowdhary A; Randhawa HS; Sundar G; Kathuria S; Prakash A; Khan Z; Sun S; Xu J
    J Med Microbiol; 2011 Jul; 60(Pt 7):961-967. PubMed ID: 21393452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptococcus neoformans differential gene expression detected in vitro and in vivo with green fluorescent protein.
    del Poeta M; Toffaletti DL; Rude TH; Sparks SD; Heitman J; Perfect JR
    Infect Immun; 1999 Apr; 67(4):1812-20. PubMed ID: 10085022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multilocus microsatellite typing for Cryptococcus neoformans var. grubii.
    Hanafy A; Kaocharoen S; Jover-Botella A; Katsu M; Iida S; Kogure T; Gonoi T; Mikami Y; Meyer W
    Med Mycol; 2008 Nov; 46(7):685-96. PubMed ID: 18608927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in mitochondrial genome organization of Cryptococcus neoformans strains.
    Litter J; Keszthelyi A; Hamari Z; Pfeiffer I; Kucsera J
    Antonie Van Leeuwenhoek; 2005; 88(3-4):249-55. PubMed ID: 16284931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An efficiently regulated promoter system for Cryptococcus neoformans utilizing the CTR4 promoter.
    Ory JJ; Griffith CL; Doering TL
    Yeast; 2004 Aug; 21(11):919-26. PubMed ID: 15334556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominance of Cryptococcus neoformans var. grubii multilocus sequence type 5 and emergence of isolates with non-wild-type minimum inhibitory concentrations to fluconazole: a multi-centre study in China.
    Fan X; Xiao M; Chen S; Kong F; Dou HT; Wang H; Xiao YL; Kang M; Sun ZY; Hu ZD; Wan Z; Chen SL; Liao K; Chu YZ; Hu TS; Zou GL; Hou X; Zhang L; Zhao YP; Xu YC; Liu ZY
    Clin Microbiol Infect; 2016 Oct; 22(10):887.e1-887.e9. PubMed ID: 27432767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of Cryptococcus gattii and Cryptococcus neoformans var. grubii from the flowers and bark of Eucalyptus trees in India.
    Gugnani HC; Mitchell TG; Litvintseva AP; Lengeler KB; Heitman J; Kumar A; Basu S; Paliwal-Joshi A
    Med Mycol; 2005 Sep; 43(6):565-9. PubMed ID: 16323312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seasonal variations in the prevalence of Cryptococcus neoformans var. grubii and Cryptococcus gattii in decayed wood inside trunk hollows of diverse tree species in north-western India: a retrospective study.
    Randhawa HS; Kowshik T; Chowdhary A; Prakash A; Khan ZU; Xu J
    Med Mycol; 2011 Apr; 49(3):320-3. PubMed ID: 20854229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of myristoyl-CoA:protein N-myristoyltransferases from three pathogenic fungi: Cryptococcus neoformans, Histoplasma capsulatum, and Candida albicans.
    Lodge JK; Johnson RL; Weinberg RA; Gordon JI
    J Biol Chem; 1994 Jan; 269(4):2996-3009. PubMed ID: 8300631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning, phylogenetic analysis and three-dimensional modeling of Cu,Zn superoxide dismutase (CnSOD1) from three varieties of Cryptococcus neoformans.
    Chaturvedi S; Hamilton AJ; Hobby P; Zhu G; Lowry CV; Chaturvedi V
    Gene; 2001 May; 268(1-2):41-51. PubMed ID: 11368899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recapitulation of the sexual cycle of the primary fungal pathogen Cryptococcus neoformans var. gattii: implications for an outbreak on Vancouver Island, Canada.
    Fraser JA; Subaran RL; Nichols CB; Heitman J
    Eukaryot Cell; 2003 Oct; 2(5):1036-45. PubMed ID: 14555486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infective capacity of Cryptococcus neoformans and Cryptococcus gattii in a human astrocytoma cell line.
    Olave MC; Vargas-Zambrano JC; Celis AM; Castañeda E; González JM
    Mycoses; 2017 Jul; 60(7):447-453. PubMed ID: 28338245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.